{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-007283","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2024-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.265886+00:00","generated_at":"2026-05-30T11:33:38.044419+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sonoma expands Medline distribution to Canada and OTC retail in US and Canada","bullets":["Amendment No. 1 to Distribution Agreement with Medline dated Oct 17, 2024 adds Canada and OTC wound care sales to retailers.","Original 5-year US distribution deal signed Aug 19, 2024; now covers both countries and OTC channel.","Updated investor presentation (Oct 22, 2024) highlights 20% YoY European revenue growth in Q1 FY2025 and gross margin improvement to 39%.","New FDA 510(k) clearance received Sep 2024 for OTC face/eyelid/eyelash indications and smaller product size.","Distribution expanded in Ukraine, South Korea, and EU through new partners in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-007283","json":"https://secwatch.observer/filing/0001683168-24-007283.json","markdown":"https://secwatch.observer/filing/0001683168-24-007283.md","text":"https://secwatch.observer/filing/0001683168-24-007283.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824007283/0001683168-24-007283-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824007283/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:33:38.044419+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}